Interventional firm C.R. Bard of Murray Hill, NJ, has acquired substantially all the assets of brachytherapy developer SourceTech Medical. Carol Stream IL-based SourceTech has been Bard's primary supplier of iodine seeds for the U.S. market. Terms of the deal were not disclosed.
By AuntMinnie.com staff writersJune 16, 2003
Related Reading
Bard taps SVP/CFO, February 28, 2003
Bard signs off on succession plan, February 13, 2003
Bard posts sales gains in Q4, 2002, January 29, 2003
Bard expects up to 8% growth in 2003, December 13, 2002
C.R. Bard shows first-quarter increase, April 17, 2002
Copyright © 2003 AuntMinnie.com